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reserves surgery for treatment failure.
Method: This observational study over 2 years analysed outcome mea-
sures on patient symptoms and QOL scores. The QOL scores were recorded
before and after respective procedure using SF 36 QOL Assessment Form .
Result: The median age was 48(28e77) years. 95.83% patients completed
the SF-36 form. This revealed that their quality of life improved signiﬁ-
cantly in physical functioning, pain, social functioning and mental health.
Conclusion: QOL data is rarely acquired in surgery so adds new knowledge
to the study by using available tools to assess QOL in patients undergoing
surgical treatment. Our study shows improvement in the QOL in patients
treated with Botox for chronic anal ﬁssure at follow up.http://dx.doi.org/10.1016/j.ijsu.2016.08.160
0830: EXTENDED VTE PROPHYLAXIS AFTER COLORECTAL CANCER SUR-
GERY e WHERE'S THE EVIDENCE?
C. Sproson 1,*, M. Lee 1, R. Kallam 2. 1 Shefﬁeld Teaching Hospitals NHS
Foundation Trust, South Yorkshire, UK; 2Northern Lincolnshire and Goole NHS
Foundation Trust, Lincolnshire, UK.
Background: NICE recommends extending pharmacological thrombo-
prophylaxis to 28-days postoperatively following abdominopelvic cancer
surgery. This is based on a 2009 Cochrane Review, which used data over a
decade old and compared extended thromboprophylaxis with placebo. In
current practice, where a minimum of in-hospital pharmacological
thromboprophylaxis is standard, is there evidence to support extended
prophylaxis following colorectal cancer surgery?
Aim: To report current incidence of post-discharge symptomatic VTE in
patients receiving only in-hospital pharmacological thromboprophylaxis
after colorectal cancer surgery.
Method: Two reviewers conducted a systematic review of the PubMed
Database using PRISMA guidelines. To ensure assessment of contemporary
data, only articles published after the 2009 Cochrane Review were
included.
Result: Initial search identiﬁed 50 abstracts. Final analysis included four
articles: one RCT and three retrospective cohorts. Data for 682 patients
revealed an incidence of 0.7% post-discharge symptomatic VTE at 30-days
post colorectal cancer surgery.
Conclusion: Current evidence suggests low incidence of post-discharge
symptomatic VTE following colorectal cancer surgery. The beneﬁt of
extending thromboprophylaxis is therefore questionable. In-hospital
thromboprophylaxis, enhanced recovery protocols and modern surgical
techniques have likely out-dated the evidence upon which national rec-
ommendations are based. Awell-powered RCT comparing in-hospital with
extended thromboprophylaxis is necessary to inform revised national
recommendations.http://dx.doi.org/10.1016/j.ijsu.2016.08.161
0871: EFFECTIVENESS OF THE BRITISH SOCIETY OF GASTROENTER-
OLOGY GUIDELINES FOR SURVEILLANCE COLONOSCOPIES ON COLONIC
ADENOMAS
S. Chandramoorthy 1,*, P. Soor 2, M. Wall 3, R. Ransford 2, E. Leung 3. 1Hull
York Medical School, York, UK; 2 St Georges University of London, London, UK;
3University of Birmingham, Birmingham, UK.
Introduction: The British Society of Gastroenterology (BSG) has set clear
guidelines on surveillance colonoscopy for adenomatous polyps. This
study aims to determine if these guidelines were adhered to in an
accredited unit.
Method: All patients who underwent surveillance colonoscopies between
October 2014 and 2015were retrospectively included. Information relating
to polyp number, size, and histology were collected and their subsequent
schedule colonoscopy was then compared with the BSG guidelines.Result: Out of the 106 cases detected, 62% (66/106) were not compliant to
the BSG guidelines (p>0.05). 49% (52/106) of the cases were requested by
gastroenterology of which 62% (32/52) were not compliant to the BSG
guidelines and on average were requested 35.4 months earlier than
scheduled. 51% (54/106) of the cases were requested by surgery of which
59% (32/54) were not compliant to the BSG guidelines and on averagewere
requested 36.5 months earlier than scheduled.
Conclusion: Too many surveillance colonoscopies were performed in our
unit and in around 60% cases nearly three years earlier than required.
Targeting the reasons for non-compliance could potentially reduce work-
load and improve efﬁciency in an over-stretched colonoscopy unit.http://dx.doi.org/10.1016/j.ijsu.2016.08.162
0883: OUTCOMES OF EMERGENCY LAPAROSCOPIC COLONIC RESEC-
TION: A SINGLE CENTRE EXPERIENCE
K. Mccoll 2,*, A. Amer 1, P. Ainley 1, K. Shahi 1, D. Borowski 1, D. Garg 1. 1North
Tees and Hartlepool NHS Foundation Trust, Stockton on Tees, UK; 2Newcastle
University, Newcastle upon Tyne, UK.
Introduction: Laparoscopic colonic resection in the emergency setting has
not been met with comparable enthusiasm as that in the elective setting.
We describe the 5-year experience of emergency laparoscopic colonic
resection at a single colorectal unit.
Method: Data for emergency laparoscopic colonic resections was collected
from a prospectively-maintained database for a single surgeon at a colo-
rectal unit between 2010e2015. Outcomes were compared to average data
for emergency open colonic resection within the department.
Result: A total of 66 patients were included in this studywith amedian age
of 62 years. Average operating time was 190 minutes (compared to 144
minutes for open emergency resections). The conversion rate to open
resectionwas 9%. Intraoperative complications occurred in 6% of cases and
included bleeding and bowel injury. Postoperative complications (30-day)
were mainly infective and occurred in 13.6% of cases. No anastomotic leaks
were identiﬁed in this cohort. Median postoperative stay was 6 days
compared to 7 days for open surgery. For malignant colonic pathology, R1
resections occurred in 9.5% of cases and median lymph node yield was 20.
Conclusion: Our data conﬁrms the feasibility and safety of colonic resec-
tion surgery in the emergency setting for benign and malignant disease.http://dx.doi.org/10.1016/j.ijsu.2016.08.163
0910: THE INCIDENCE AND IMPLICATIONS OF INTESTINAL INJURY IN
LAPAROSCOPIC COLORECTAL SURGERY
P. Chaichanavichkij*, T. Killeen, K. Aryal. James Paget University Hospitals
NHS Foundation Trust, Great Yarmouth, UK.
Aim: Intestinal injury (II) is a recognised complication of laparoscopic
surgery in general, there is little evidence on the actual incidence of II in
laparoscopic colorectal surgery (LCS). This study investigates the incidence
and consequences of II in LCS.
Method: A systematic literature search was conducted through PubMed,
Ovid, and the Cochrane Database to identify primary studies in the English
Language which reported incidence of II in LCS for benign and malignant
diseases between January 2000 and October 2015. Information on de-
mographics, operative characteristics, previous abdominal surgery, con-
version rate, and II was extracted from the selected studies.
Result: Forty-three studies were included, pertaining to 29600 patients.
The overall intra-operative complication rate was 5.7% (n ¼ 1297/22931),
conversion rate was 8.6% (n ¼ 2351/27368), and mortality rate was 1.0%
(n ¼ 297/28943).
II occurred in 365 patients (1.2%) and forms 28.1% of all intra-operative
complications. The majority of injuries were diagnosed intra-operatively
(98.6%, n¼ 360), ofwhich11.4% (n¼ 41) required conversion toopen surgery.
Among the 1.4% (n ¼ 5) of II diagnosed post-operatively, 60% (n ¼ 3) died.
